TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $180,648 | -12.7% | 11,580 | -21.6% | 0.05% | -43.4% |
| Q2 2022 | $207,000 | +4.5% | 14,772 | +6.7% | 0.08% | +219.2% |
| Q1 2022 | $198,000 | -34.0% | 13,850 | -37.1% | 0.03% | -51.9% |
| Q4 2021 | $300,000 | -85.7% | 22,019 | -82.8% | 0.05% | -73.3% |
| Q3 2021 | $2,095,000 | +52.4% | 127,875 | +56.6% | 0.20% | +4.7% |
| Q2 2021 | $1,375,000 | +329.7% | 81,675 | +358.3% | 0.19% | -17.5% |
| Q2 2020 | $320,000 | +1.3% | 17,820 | -14.3% | 0.23% | +188.9% |
| Q1 2020 | $316,000 | +17.0% | 20,800 | +52.1% | 0.08% | +478.6% |
| Q4 2019 | $270,000 | -61.4% | 13,674 | -66.4% | 0.01% | -62.2% |
| Q3 2019 | $700,000 | +293.3% | 40,674 | +303.8% | 0.04% | +311.1% |
| Q2 2019 | $178,000 | – | 10,074 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |